Ticker
ABMD

Price
377.23
Stock movement down
-0.85 (-0.22%)
Company name
ABIOMED Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
17.21B
Ent value
17.25B
Price/Sales
16.68
Price/Book
11.45
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
126.09
Forward P/E
82.73
PEG
-
EPS growth
-
1 year return
15.72%
3 year return
24.76%
5 year return
13.56%
10 year return
39.04%
Last updated: 2022-11-29

DIVIDENDS

ABMD does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E126.09
Price to OCF83.38
Price to FCF92.76
Price to EBITDA126.00
EV to EBITDA126.27

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales16.68
Price to Book11.45
EV to Sales16.72

FINANCIALS

Per share

Loading...
Per share data
Current share count45.63M
EPS (TTM)2.97
FCF per share (TTM)4.04

Income statement

Loading...
Income statement data
Revenue (TTM)1.03B
Gross profit (TTM)843.60M
Operating income (TTM)140.72M
Net income (TTM)136.50M
EPS (TTM)2.97
EPS (1y forward)4.56

Margins

Loading...
Margins data
Gross margin (TTM)81.76%
Operating margin (TTM)13.64%
Profit margin (TTM)13.23%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash132.82M
Net receivables90.61M
Total current assets976.47M
Goodwill76.79M
Intangible assets39.52M
Property, plant and equipment0.00
Total assets1.67B
Accounts payable35.35M
Short/Current long term debt0.00
Total current liabilities138.46M
Total liabilities170.07M
Shareholder's equity1.50B
Net tangible assets1.39B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)206.42M
Capital expenditures (TTM)20.87M
Free cash flow (TTM)185.55M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity9.08%
Return on Assets8.16%
Return on Invested Capital9.08%
Cash Return on Invested Capital12.34%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open377.51
Daily high378.18
Daily low377.01
Daily Volume830K
All-time high449.75
1y analyst estimate325.83
Beta1.32
EPS (TTM)2.97
Dividend per share-
Ex-div date-
Next earnings date1 Feb 2023

Downside potential

Loading...
Downside potential data
ABMDS&P500
Current price drop from All-time high-16.12%-17.12%
Highest price drop-94.31%-56.47%
Date of highest drop9 Oct 20029 Mar 2009
Avg drop from high-47.65%-11.46%
Avg time to new high46 days13 days
Max time to new high3756 days1805 days
COMPANY DETAILS
ABMD (ABIOMED Inc) company logo
Marketcap
17.21B
Marketcap category
Large-cap
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.
Employees
2003
Investor relations
-
SEC filings
CEO
Michael R. Minogue
Country
USA
City
Danvers
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Most S&P 500 investors got a little gain this month. But investors willing to look off the beaten path found huge gains.
30. november 2022
Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.
22. november 2022
In this article, we will take a look at the 15 biggest medical device companies in the world. If you want to skip our introduction to the industry, then take a look at 5 Biggest Medical Device Compani...
20. november 2022
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently made headlines by announcing it will acquire medical device company Abiomed for $16.6 billion in an all-cash transaction. The buyout off...
10. november 2022
Why he believes Abiomed is worth a "shock and awe" price. How Abiomed will strengthen Johnson & Johnson's medical device portfolio. Also, Motley Fool host Alison Southwick and Motley Fool personal f...
5. november 2022
It's not surprising that Johnson & Johnson (NYSE: JNJ) has a deal in the works to buy Abiomed (NASDAQ: ABMD), the maker of the Impella heart pump. More than 11 years ago, then-Johnson & Johnson CFO D...
5. november 2022
Here is how Molina (MOH) and Abiomed (ABMD) have performed compared to their sector so far this year.
2. november 2022
Companies in The News Are: ABMD,ARCB,MPC,TAP
2. november 2022
Abiomed (ABMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
2. november 2022
We're in the middle of earnings season, so it would be natural to assume that earnings reports are the biggest drivers of stocks during the season. But that isn't the case with a bunch that soared yes...
2. november 2022
Next page